BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 140 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,552,049 | +5.1% | 2,479,103 | +4.5% | 1.48% | +6.4% |
| Q2 2023 | $16,699,676 | -55.7% | 2,372,113 | -47.5% | 1.40% | -46.9% |
| Q1 2023 | $37,702,838 | +273.0% | 4,520,724 | +413.4% | 2.63% | +197.1% |
| Q4 2022 | $10,107,991 | +175.9% | 880,487 | +79.0% | 0.88% | +105.8% |
| Q4 2020 | $3,664,297 | -6.7% | 491,852 | -57.0% | 0.43% | -50.7% |
| Q3 2020 | $3,926,930 | -83.0% | 1,143,211 | -76.4% | 0.87% | -72.4% |
| Q2 2020 | $23,099,729 | +53.1% | 4,847,792 | -35.7% | 3.17% | -15.5% |
| Q1 2020 | $15,084,744 | -10.8% | 7,542,372 | +53.8% | 3.75% | +25.5% |
| Q4 2019 | $16,920,387 | +802.4% | 4,904,460 | +649.4% | 2.99% | +413.4% |
| Q3 2019 | $1,875,028 | +11.4% | 654,460 | +47.3% | 0.58% | +23.6% |
| Q2 2019 | $1,683,745 | -49.9% | 444,260 | +7.6% | 0.47% | -51.9% |
| Q1 2019 | $3,360,811 | +154.0% | 412,876 | +151.8% | 0.98% | +36.9% |
| Q4 2018 | $1,323,149 | +16.4% | 163,959 | +10.1% | 0.72% | +43.5% |
| Q3 2018 | $1,136,557 | +33.2% | 148,959 | 0.0% | 0.50% | +27.9% |
| Q2 2018 | $853,535 | +20.1% | 148,959 | 0.0% | 0.39% | +18.2% |
| Q1 2018 | $710,534 | -27.0% | 148,959 | -24.9% | 0.33% | -41.1% |
| Q4 2017 | $973,746 | – | 198,319 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |